Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Shares Outstanding (Diluted Average) (2018 - 2025)

Historic Shares Outstanding (Diluted Average) for Ironwood Pharmaceuticals (IRWD) over the last 10 years, with Q1 2025 value amounting to $161.0 million.

  • Ironwood Pharmaceuticals' Shares Outstanding (Diluted Average) rose 207.61% to $161.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $161.0 million, marking a year-over-year increase of 207.61%. This contributed to the annual value of $160.7 million for FY2020, which is 296.88% up from last year.
  • As of Q1 2025, Ironwood Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $161.0 million, which was up 207.61% from $159.0 million recorded in Q2 2024.
  • In the past 5 years, Ironwood Pharmaceuticals' Shares Outstanding (Diluted Average) ranged from a high of $161.0 million in Q1 2025 and a low of $155.4 million during Q2 2023
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $158.4 million (2024), whereas its average is $158.3 million.
  • In the last 5 years, Ironwood Pharmaceuticals' Shares Outstanding (Diluted Average) surged by 234.73% in 2024 and then soared by 207.61% in 2025.
  • Quarter analysis of 3 years shows Ironwood Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $155.4 million in 2023, then increased by 2.35% to $159.0 million in 2024, then grew by 1.23% to $161.0 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $161.0 million in Q1 2025, compared to $159.0 million in Q2 2024 and $157.7 million in Q1 2024.